| Year |
Citation |
Score |
| 2023 |
Mitra R, Adams CM, Eischen CM. Decoding the lncRNAome Across Diverse Cellular Stresses Reveals Core p53-effector Pan-cancer Suppressive lncRNAs. Cancer Research Communications. 3: 842-859. PMID 37377895 DOI: 10.1158/2767-9764.CRC-22-0473 |
0.331 |
|
| 2023 |
Adams CM, Mitra R, Xiao Y, Michener P, Palazzo J, Chao A, Gour J, Cassel J, Salvino JM, Eischen CM. Targeted MDM2 degradation reveals a new vulnerability for p53 inactivated triple negative breast cancer. Cancer Discovery. PMID 36734633 DOI: 10.1158/2159-8290.CD-22-1131 |
0.418 |
|
| 2022 |
Grieb BC, Eischen CM. MTBP and MYC: A Dynamic Duo in Proliferation, Cancer, and Aging. Biology. 11. PMID 35741402 DOI: 10.3390/biology11060881 |
0.304 |
|
| 2021 |
Porazzi P, Petruk S, Pagliaroli L, De Dominici M, Deming D, Puccetti MV, Kushinsky S, Kumar G, Minieri V, Barbieri E, Deliard S, Grande A, Trizzino M, Gardini A, Canaani E, ... ... Eischen CM, et al. Targeting chemotherapy to de-condensed H3K27me3-marked chromatin of AML cells enhances leukemia suppression. Cancer Research. PMID 34903608 DOI: 10.1158/0008-5472.CAN-21-1297 |
0.318 |
|
| 2020 |
Wohlberedt K, Klusmann I, Derevyanko PK, Henningsen K, Choo JAMY, Manzini V, Magerhans A, Giansanti C, Eischen CM, Jochemsen AG, Dobbelstein M. Mdm4 supports DNA replication in a p53-independent fashion. Oncogene. PMID 32427989 DOI: 10.1038/S41388-020-1325-1 |
0.515 |
|
| 2020 |
Thomas LR, Adams CM, Fesik SW, Eischen CM, Tansey WP. Targeting MYC through WDR5. Molecular & Cellular Oncology. 7: 1709388. PMID 32158922 DOI: 10.1080/23723556.2019.1709388 |
0.368 |
|
| 2020 |
Mitra R, Adams CM, Jiang W, Greenawalt E, Eischen CM. Pan-cancer analysis reveals cooperativity of both strands of microRNA that regulate tumorigenesis and patient survival. Nature Communications. 11: 968. PMID 32080184 DOI: 10.1038/S41467-020-14713-2 |
0.406 |
|
| 2020 |
Qin G, Mallik S, Mitra R, Li A, Jia P, Eischen CM, Zhao Z. MicroRNA and transcription factor co-regulatory networks and subtype classification of seminoma and non-seminoma in testicular germ cell tumors. Scientific Reports. 10: 852. PMID 31965022 DOI: 10.1038/S41598-020-57834-W |
0.33 |
|
| 2019 |
Thomas LR, Adams CM, Wang J, Weissmiller AM, Creighton J, Lorey SL, Liu Q, Fesik SW, Eischen CM, Tansey WP. Interaction of the oncoprotein transcription factor MYC with its chromatin cofactor WDR5 is essential for tumor maintenance. Proceedings of the National Academy of Sciences of the United States of America. PMID 31767764 DOI: 10.1073/Pnas.1910391116 |
0.404 |
|
| 2019 |
Stier MT, Mitra R, Nyhoff LE, Goleniewska K, Zhang J, Puccetti MV, Casanova HC, Seegmiller AC, Newcomb DC, Kendall PL, Eischen CM, Peebles RS. IL-33 Is a Cell-Intrinsic Regulator of Fitness during Early B Cell Development. Journal of Immunology (Baltimore, Md. : 1950). PMID 31391233 DOI: 10.4049/Jimmunol.1900408 |
0.315 |
|
| 2019 |
Puccetti MV, Adams CM, Dan TD, Palagani A, Simone BA, DeAngelis T, Eischen CM, Simone NL. miR-21 is required for hematopoietic cell viability following radiation exposure. International Journal of Radiation Oncology, Biology, Physics. PMID 31039423 DOI: 10.1016/J.Ijrobp.2019.04.020 |
0.3 |
|
| 2019 |
Puccetti MV, Adams CM, Kushinsky S, Eischen CM. Smarcal1 and Zranb3 protect replication forks from Myc-induced DNA replication stress. Cancer Research. PMID 30610086 DOI: 10.1158/0008-5472.Can-18-2705 |
0.444 |
|
| 2018 |
Adams CM, Clark-Garvey S, Porcu P, Eischen CM. Targeting the Bcl-2 Family in B Cell Lymphoma. Frontiers in Oncology. 8: 636. PMID 30671383 DOI: 10.3389/Fonc.2018.00636 |
0.358 |
|
| 2018 |
Greenawalt EJ, Edmonds MD, Jain N, Adams CM, Mitra R, Eischen CM. Targeting of SGK1 by miR-576-3p inhibits lung adenocarcinoma migration and invasion. Molecular Cancer Research : McR. PMID 30257988 DOI: 10.1158/1541-7786.Mcr-18-0364 |
0.341 |
|
| 2018 |
Olivos DJ, Perrien DS, Hooker A, Cheng YH, Fuchs RK, Hong JM, Bruzzaniti A, Chun K, Eischen CM, Kacena MA, Mayo LD. The proto-oncogene function of Mdm2 in bone. Journal of Cellular Biochemistry. PMID 30011084 DOI: 10.1002/Jcb.27133 |
0.338 |
|
| 2017 |
Mitra R, Chen X, Greenawalt EJ, Maulik U, Jiang W, Zhao Z, Eischen CM. Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition. Nature Communications. 8: 1604. PMID 29150601 DOI: 10.1038/S41467-017-01781-0 |
0.311 |
|
| 2017 |
Adams CM, Mitra R, Gong J, Eischen CM. Non-Hodgkin and Hodgkin lymphomas select for overexpression of BCLW. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 28855351 DOI: 10.1158/1078-0432.Ccr-17-1144 |
0.344 |
|
| 2017 |
Feeley K, Adams CM, Mitra R, Eischen CM. Mdm2 is required for survival and growth of p53-deficient cancer cells. Cancer Research. PMID 28576884 DOI: 10.1158/0008-5472.Can-17-0809 |
0.545 |
|
| 2017 |
Moyo TK, Wilson CS, Moore DJ, Eischen CM. Myc enhances B-cell receptor signaling in precancerous B cells and confers resistance to Btk inhibition. Oncogene. PMID 28368423 DOI: 10.1038/Onc.2017.95 |
0.368 |
|
| 2017 |
Adams CM, Kim AS, Mitra R, Choi JK, Gong JZ, Eischen CM. BCL-W has a fundamental role in B cell survival and lymphomagenesis. The Journal of Clinical Investigation. PMID 28094768 DOI: 10.1172/Jci89486 |
0.415 |
|
| 2017 |
Adams CM, Mitra R, Gong JZ, Kim AS, Choi JK, Eischen CM. Abstract 02: BCL-W significantly contributes to B-cell lymphoma survival and development Clinical Cancer Research. 23: 2-2. DOI: 10.1158/1557-3265.Hemmal17-02 |
0.419 |
|
| 2016 |
Eischen CM. Role of MDM2 and MDMX in DNA repair. Journal of Molecular Cell Biology. PMID 27932484 DOI: 10.1093/Jmcb/Mjw052 |
0.548 |
|
| 2016 |
Puccetti MV, Fischer MA, Arrate MP, Boyd KL, Duszynski RJ, Bétous R, Cortez D, Eischen CM. Defective replication stress response inhibits lymphomagenesis and impairs lymphocyte reconstitution. Oncogene. PMID 27797382 DOI: 10.1038/Onc.2016.408 |
0.441 |
|
| 2016 |
Liu S, Mitra R, Zhao MM, Fan W, Eischen CM, Yin F, Zhao Z. The potential roles of long non-coding RNAs (lncRNAs) in glioblastoma development. Molecular Cancer Therapeutics. PMID 27784795 DOI: 10.1158/1535-7163.Mct-16-0320 |
0.352 |
|
| 2016 |
Oran AR, Adams CM, Zhang XY, Gennaro VJ, Pfeiffer HK, Mellert HS, Seidel HE, Mascioli K, Kaplan J, Gaballa MR, Shen C, Rigoutsos I, King MP, Cotney JL, Arnold JJ, ... ... Eischen CM, et al. Multi-focal control of mitochondrial gene expression by oncogenic MYC provides potential therapeutic targets in cancer. Oncotarget. PMID 27590350 DOI: 10.18632/Oncotarget.11718 |
0.368 |
|
| 2016 |
Eischen CM. Genome Stability Requires p53. Cold Spring Harbor Perspectives in Medicine. 6. PMID 27252396 DOI: 10.1101/Cshperspect.A026096 |
0.423 |
|
| 2016 |
Thompson MA, Edmonds MD, Liang S, McClintock-Treep S, Wang X, Li S, Eischen CM. miR-31 and miR-17-5p levels change during transformation of follicular lymphoma. Human Pathology. 50: 118-26. PMID 26997445 DOI: 10.1016/J.Humpath.2015.11.011 |
0.349 |
|
| 2016 |
Adams CM, Eischen CM. Histone deacetylase inhibition reveals a tumor-suppressive function of MYC-regulated miRNA in breast and lung carcinoma. Cell Death and Differentiation. PMID 26915294 DOI: 10.1038/Cdd.2016.9 |
0.392 |
|
| 2016 |
Adams CM, Hiebert SW, Eischen CM. Abstract A24: HDAC inhibition unmasks a microRNA-mediated mechanism of tumor suppression Cancer Research. 76. DOI: 10.1158/1538-7445.Nonrna15-A24 |
0.396 |
|
| 2016 |
Edmonds MD, Boyd KL, Moyo TK, Mitra R, Duszynski RJ, Arrate MP, Chen X, Zhao Z, Blackwell TS, Eischen CM. Abstract LB-168: MicroRNA-31 initiates lung tumorigenesis and promotes mutant KRAS-driven lung cancer Cancer Research. 76. DOI: 10.1158/1538-7445.Am2016-Lb-168 |
0.302 |
|
| 2016 |
Taylor A, Adams C, Zhang X, Gennaro V, Cotney J, Shadel G, Cameron C, Eischen C, McMahon S. Abstract 1256: Multi-focal control of mitochondrial gene expression by oncogenic MYC provides effective therapeutic targets in cancer Cancer Research. 76: 1256-1256. DOI: 10.1158/1538-7445.Am2016-1256 |
0.369 |
|
| 2015 |
Adams CM, Hiebert SW, Eischen CM. Myc induces miRNA-mediated apoptosis in response to HDAC inhibition in hematologic malignancies. Cancer Research. PMID 26676759 DOI: 10.1158/0008-5472.Can-15-1751 |
0.426 |
|
| 2015 |
Poole LA, Zhao R, Glick GG, Lovejoy CA, Eischen CM, Cortez D. SMARCAL1 maintains telomere integrity during DNA replication. Proceedings of the National Academy of Sciences of the United States of America. PMID 26578802 DOI: 10.1073/Pnas.1510750112 |
0.436 |
|
| 2015 |
Thomas LR, Foshage AM, Weissmiller AM, Popay TM, Grieb BC, Qualls SJ, Ng V, Carboneau B, Lorey S, Eischen CM, Tansey WP. Interaction of MYC with host cell factor-1 is mediated by the evolutionarily conserved Myc box IV motif. Oncogene. PMID 26522729 DOI: 10.1038/Onc.2015.416 |
0.406 |
|
| 2015 |
Tonsing-Carter E, Bailey BJ, Saadatzadeh MR, Ding J, Wang H, Sinn AL, Peterman KM, Spragins TK, Silver JM, Sprouse AA, Georgiadis TM, Gunter TZ, Long EC, Minto RE, Marchal CC, ... ... Eischen CM, et al. Potentiation of carboplatin-mediated DNA damage by the Mdm2 modulator Nutlin-3a in a humanized orthotopic breast-to-lung metastatic model. Molecular Cancer Therapeutics. PMID 26494859 DOI: 10.1158/1535-7163.Mct-15-0237 |
0.422 |
|
| 2015 |
McGirt LY, Jia P, Baerenwald DA, Duszynski RJ, Dahlman KB, Zic JA, Zwerner JP, Hucks D, Dave U, Zhao Z, Eischen CM. Whole genome sequencing reveals oncogenic mutations in mycosis fungoides. Blood. PMID 26082451 DOI: 10.1182/Blood-2014-11-611194 |
0.37 |
|
| 2015 |
Carrillo AM, Hicks M, Khabele D, Eischen CM. Pharmacologically increasing Mdm2 inhibits DNA repair and cooperates with genotoxic agents to kill p53 inactivated ovarian cancer cells. Molecular Cancer Research : McR. PMID 25964101 DOI: 10.1158/1541-7786.Mcr-15-0089 |
0.553 |
|
| 2015 |
Mitra R, Lin CC, Eischen CM, Bandyopadhyay S, Zhao Z. Concordant dysregulation of miR-5p and miR-3p arms of the same precursor microRNA may be a mechanism in inducing cell proliferation and tumorigenesis: a lung cancer study. Rna (New York, N.Y.). 21: 1055-65. PMID 25852169 DOI: 10.1261/Rna.048132.114 |
0.401 |
|
| 2015 |
Thomas LR, Wang Q, Grieb BC, Phan J, Foshage AM, Sun Q, Olejniczak ET, Clark T, Dey S, Lorey S, Alicie B, Howard GC, Cawthon B, Ess KC, Eischen CM, et al. Interaction with WDR5 promotes target gene recognition and tumorigenesis by MYC. Molecular Cell. 58: 440-52. PMID 25818646 DOI: 10.2210/Pdb6Dak/Pdb |
0.378 |
|
| 2015 |
Carrillo AM, Bouska A, Arrate MP, Eischen CM. Mdmx promotes genomic instability independent of p53 and Mdm2. Oncogene. 34: 846-56. PMID 24608433 DOI: 10.1038/Onc.2014.27 |
0.768 |
|
| 2015 |
Adams CM, Eischen CM. Abstract A14: Epigenetic alterations reactivate a novel mechanism of Myc-induced apoptosis Molecular Cancer Research. 13. DOI: 10.1158/1557-3125.Myc15-A14 |
0.423 |
|
| 2014 |
Adams CM, Eischen CM. Cell survival is dicey without Dicer. Molecular & Cellular Oncology. 1. PMID 25558471 DOI: 10.4161/23723548.2014.961825 |
0.368 |
|
| 2014 |
Edmonds MD, Eischen CM. Differences in miRNA expression in early stage lung adenocarcinomas that did and did not relapse. Plos One. 9: e101802. PMID 25028925 DOI: 10.1371/Journal.Pone.0101802 |
0.306 |
|
| 2014 |
Mitra R, Edmonds MD, Sun J, Zhao M, Yu H, Eischen CM, Zhao Z. Reproducible combinatorial regulatory networks elucidate novel oncogenic microRNAs in non-small cell lung cancer. Rna (New York, N.Y.). 20: 1356-68. PMID 25024357 DOI: 10.1261/Rna.042754.113 |
0.305 |
|
| 2014 |
Grieb BC, Chen X, Eischen CM. MTBP is overexpressed in triple-negative breast cancer and contributes to its growth and survival. Molecular Cancer Research : McR. 12: 1216-24. PMID 24866769 DOI: 10.1158/1541-7786.Mcr-14-0069 |
0.346 |
|
| 2014 |
Adams CM, Eischen CM. Inactivation of p53 is insufficient to allow B cells and B-cell lymphomas to survive without Dicer. Cancer Research. 74: 3923-34. PMID 24840646 DOI: 10.1158/0008-5472.Can-13-1866 |
0.497 |
|
| 2014 |
Grieb BC, Gramling MW, Arrate MP, Chen X, Beauparlant SL, Haines DS, Xiao H, Eischen CM. Oncogenic protein MTBP interacts with MYC to promote tumorigenesis. Cancer Research. 74: 3591-602. PMID 24786788 DOI: 10.1158/0008-5472.Can-13-2149 |
0.385 |
|
| 2014 |
Eischen CM, Lozano G. The Mdm network and its regulation of p53 activities: a rheostat of cancer risk. Human Mutation. 35: 728-37. PMID 24488925 DOI: 10.1002/Humu.22524 |
0.484 |
|
| 2014 |
Carrillo AM, Bouska A, Arrate MP, Eischen CM. Mdmx promotes genomic instability independent of p53 and Mdm2 Oncogene. DOI: 10.1038/onc.2014.27 |
0.758 |
|
| 2013 |
Zhang X, Hagen J, Muniz VP, Smith T, Coombs GS, Eischen CM, Mackie DI, Roman DL, Van Rheeden R, Darbro B, Tompkins VS, Quelle DE. RABL6A, a novel RAB-like protein, controls centrosome amplification and chromosome instability in primary fibroblasts. Plos One. 8: e80228. PMID 24282525 DOI: 10.1371/Journal.Pone.0080228 |
0.533 |
|
| 2013 |
Wells CE, Bhaskara S, Stengel KR, Zhao Y, Sirbu B, Chagot B, Cortez D, Khabele D, Chazin WJ, Cooper A, Jacques V, Rusche J, Eischen CM, McGirt LY, Hiebert SW. Inhibition of histone deacetylase 3 causes replication stress in cutaneous T cell lymphoma. Plos One. 8: e68915. PMID 23894374 DOI: 10.1371/Journal.Pone.0068915 |
0.425 |
|
| 2013 |
Melo AN, Bouska A, Arrate MP, Eischen CM. Abstract 1768: The oncogene Mdmx promotes genomic instability independent of p53. Cancer Research. 73: 1768-1768. DOI: 10.1158/1538-7445.Am2013-1768 |
0.571 |
|
| 2012 |
Melo AN, Eischen CM. Protecting the genome from mdm2 and mdmx. Genes & Cancer. 3: 283-90. PMID 23150761 DOI: 10.1177/1947601912454139 |
0.547 |
|
| 2012 |
Eischen CM, Boyd K. Decreased Mdm2 Expression Inhibits Tumor Development and Extends Survival Independent of Arf and Dependent on p53 Plos One. 7. PMID 23029416 DOI: 10.1371/Journal.Pone.0046148 |
0.512 |
|
| 2012 |
Anderson PD, McKissic SA, Logan M, Roh M, Franco OE, Wang J, Doubinskaia I, van der Meer R, Hayward SW, Eischen CM, Eltoum IE, Abdulkadir SA. Nkx3.1 and Myc crossregulate shared target genes in mouse and human prostate tumorigenesis. The Journal of Clinical Investigation. 122: 1907-19. PMID 22484818 DOI: 10.1172/Jci58540 |
0.339 |
|
| 2012 |
Gramling MW, Eischen CM. Suppression of Ras/Mapk pathway signaling inhibits Myc-induced lymphomagenesis. Cell Death and Differentiation. 19: 1220-7. PMID 22301919 DOI: 10.1038/Cdd.2012.1 |
0.407 |
|
| 2012 |
Anderson PD, McKissic SA, Logan M, Roh M, Franco O, Wang J, Doubinskaia I, Meer Rvd, Hayward S, Eischen C, Eltoum IA, Abdulkadir SA. Abstract 2983: Nkx3.1 and c-Myc co-regulate shared target genes involved in prostate cancer Cancer Research. 72: 2983-2983. DOI: 10.1158/1538-7445.Am2012-2983 |
0.343 |
|
| 2011 |
Cho SH, Ahn AK, Bhargava P, Lee CH, Eischen CM, McGuinness O, Boothby M. Glycolytic rate and lymphomagenesis depend on PARP14, an ADP ribosyltransferase of the B aggressive lymphoma (BAL) family. Proceedings of the National Academy of Sciences of the United States of America. 108: 15972-7. PMID 21911376 DOI: 10.1073/Pnas.1017082108 |
0.362 |
|
| 2011 |
Lushnikova T, Bouska A, Odvody J, Dupont WD, Eischen CM. Aging mice have increased chromosome instability that is exacerbated by elevated Mdm2 expression. Oncogene. 30: 4622-31. PMID 21602883 DOI: 10.1038/Onc.2011.172 |
0.686 |
|
| 2011 |
Eischen CM. Decreased Mdm2 levels after DNA damage: antibody masking or protein degradation? Cell Cycle (Georgetown, Tex.). 10: 1347. PMID 21460638 DOI: 10.4161/Cc.10.9.15437 |
0.338 |
|
| 2011 |
Eischen CM. Abstract CN05-01: Targeting Mdm2 in DNA repair and chromosome instability. Molecular Cancer Therapeutics. 10. DOI: 10.1158/1535-7163.Targ-11-Cn05-01 |
0.542 |
|
| 2010 |
Arrate MP, Vincent T, Odvody J, Kar R, Jones SN, Eischen CM. MicroRNA biogenesis is required for Myc-induced B-cell lymphoma development and survival. Cancer Research. 70: 6083-92. PMID 20587524 DOI: 10.1158/0008-5472.Can-09-4736 |
0.406 |
|
| 2010 |
Odvody J, Vincent T, Arrate MP, Grieb B, Wang S, Garriga J, Lozano G, Iwakuma T, Haines DS, Eischen CM. A deficiency in Mdm2 binding protein inhibits Myc-induced B-cell proliferation and lymphomagenesis. Oncogene. 29: 3287-96. PMID 20305689 DOI: 10.1038/Onc.2010.82 |
0.536 |
|
| 2010 |
Sluss HK, Gannon H, Coles AH, Shen Q, Eischen CM, Jones SN. Phosphorylation of p53 serine 18 upregulates apoptosis to suppress Myc-induced tumorigenesis. Molecular Cancer Research : McR. 8: 216-22. PMID 20145032 DOI: 10.1158/1541-7786.Mcr-09-0324 |
0.561 |
|
| 2010 |
Post SM, Quintás-Cardama A, Terzian T, Smith C, Eischen CM, Lozano G. p53-dependent senescence delays Emu-myc-induced B-cell lymphomagenesis. Oncogene. 29: 1260-9. PMID 19935700 DOI: 10.1038/Onc.2009.423 |
0.511 |
|
| 2009 |
Bouska A, Eischen CM. Murine double minute 2: p53-independent roads lead to genome instability or death. Trends in Biochemical Sciences. 34: 279-86. PMID 19447627 DOI: 10.1016/J.Tibs.2009.02.006 |
0.771 |
|
| 2009 |
Eischen CM, Lozano G. p53 and MDM2: antagonists or partners in crime? Cancer Cell. 15: 161-2. PMID 19249672 DOI: 10.1016/J.Ccr.2009.02.004 |
0.42 |
|
| 2009 |
Bouska A, Eischen CM. Mdm2 affects genome stability independent of p53. Cancer Research. 69: 1697-701. PMID 19244108 DOI: 10.1158/0008-5472.Can-08-3732 |
0.759 |
|
| 2009 |
Cho SH, Goenka S, Henttinen T, Gudapati P, Reinikainen A, Eischen CM, Lahesmaa R, Boothby M. PARP-14, a member of the B aggressive lymphoma family, transduces survival signals in primary B cells. Blood. 113: 2416-25. PMID 19147789 DOI: 10.1182/Blood-2008-03-144121 |
0.415 |
|
| 2008 |
Humbey O, Pimkina J, Zilfou JT, Jarnik M, Dominguez-Brauer C, Burgess DJ, Eischen CM, Murphy ME. The ARF tumor suppressor can promote the progression of some tumors. Cancer Research. 68: 9608-13. PMID 19047137 DOI: 10.1158/0008-5472.Can-08-2263 |
0.474 |
|
| 2008 |
Mudhasani R, Zhu Z, Hutvagner G, Eischen CM, Lyle S, Hall LL, Lawrence JB, Imbalzano AN, Jones SN. Loss of miRNA biogenesis induces p19Arf-p53 signaling and senescence in primary cells. The Journal of Cell Biology. 181: 1055-63. PMID 18591425 DOI: 10.1083/Jcb.200802105 |
0.432 |
|
| 2008 |
Bouska A, Lushnikova T, Plaza S, Eischen CM. Mdm2 promotes genetic instability and transformation independent of p53. Molecular and Cellular Biology. 28: 4862-74. PMID 18541670 DOI: 10.1128/Mcb.01584-07 |
0.755 |
|
| 2008 |
Iwakuma T, Tochigi Y, Van Pelt CS, Caldwell LC, Terzian T, Parant JM, Chau GP, Koch JG, Eischen CM, Lozano G. Mtbp haploinsufficiency in mice increases tumor metastasis. Oncogene. 27: 1813-20. PMID 17906694 DOI: 10.1038/Sj.Onc.1210827 |
0.515 |
|
| 2008 |
Wang P, Lushnikova T, Odvody J, Greiner TC, Jones SN, Eischen CM. Elevated Mdm2 expression induces chromosomal instability and confers a survival and growth advantage to B cells Oncogene. 27: 1590-1598. PMID 17828300 DOI: 10.1038/Sj.Onc.1210788 |
0.536 |
|
| 2007 |
Tompkins VS, Hagen J, Frazier AA, Lushnikova T, Fitzgerald MP, di Tommaso A, Ladeveze V, Domann FE, Eischen CM, Quelle DE. A novel nuclear interactor of ARF and MDM2 (NIAM) that maintains chromosomal stability. The Journal of Biological Chemistry. 282: 1322-33. PMID 17110379 DOI: 10.1074/Jbc.M609612200 |
0.525 |
|
| 2006 |
Wang P, Greiner TC, Lushnikova T, Eischen CM. Decreased Mdm2 expression inhibits tumor development induced by loss of ARF. Oncogene. 25: 3708-18. PMID 16491126 DOI: 10.1038/Sj.Onc.1209411 |
0.467 |
|
| 2005 |
Alt JR, Bouska A, Fernandez MR, Cerny RL, Xiao H, Eischen CM. Mdm2 binds to Nbs1 at sites of DNA damage and regulates double strand break repair. The Journal of Biological Chemistry. 280: 18771-81. PMID 15734743 DOI: 10.1074/Jbc.M413387200 |
0.737 |
|
| 2004 |
Eischen CM, Alt JR, Wang P. Loss of one allele of ARF rescues Mdm2 haploinsufficiency effects on apoptosis and lymphoma development. Oncogene. 23: 8931-40. PMID 15467748 DOI: 10.1038/Sj.Onc.1208052 |
0.774 |
|
| 2003 |
Alt JR, Greiner TC, Cleveland JL, Eischen CM. Mdm2 haplo-insufficiency profoundly inhibits Myc-induced lymphomagenesis. The Embo Journal. 22: 1442-50. PMID 12628936 DOI: 10.1093/Emboj/Cdg133 |
0.771 |
|
| 2002 |
Dang J, Kuo ML, Eischen CM, Stepanova L, Sherr CJ, Roussel MF. The RING domain of Mdm2 can inhibit cell proliferation. Cancer Research. 62: 1222-30. PMID 11861407 |
0.401 |
|
| 2001 |
Eischen CM, Packham G, Nip J, Fee BE, Hiebert SW, Zambetti GP, Cleveland JL. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1 Oncogene. 20: 6983-6993. PMID 11704823 DOI: 10.1038/Sj.Onc.1204892 |
0.502 |
|
| 2001 |
Braun JS, Novak R, Murray PJ, Eischen CM, Susin SA, Kroemer G, Halle A, Weber JR, Tuomanen EI, Cleveland JL. Apoptosis-inducing factor mediates microglial and neuronal apoptosis caused by pneumococcus. The Journal of Infectious Diseases. 184: 1300-9. PMID 11679919 DOI: 10.1086/324013 |
0.336 |
|
| 2001 |
Eischen CM, Roussel MF, Korsmeyer SJ, Cleveland JL. Bax loss impairs Myc-induced apoptosis and circumvents the selection of p53 mutations during Myc-mediated lymphomagenesis. Molecular and Cellular Biology. 21: 7653-62. PMID 11604501 DOI: 10.1128/Mcb.21.22.7653-7662.2001 |
0.529 |
|
| 2001 |
Eischen CM, Woo D, Roussel MF, Cleveland JL. Apoptosis triggered by Myc-induced suppression of Bcl-X(L) or Bcl-2 is bypassed during lymphomagenesis. Molecular and Cellular Biology. 21: 5063-70. PMID 11438662 DOI: 10.1128/Mcb.21.15.5063-5070.2001 |
0.364 |
|
| 2001 |
Nip J, Strom DK, Eischen CM, Cleveland JL, Zambetti GP, Hiebert SW. E2F-1 induces the stabilization of p53 but blocks p53-mediated transactivation Oncogene. 20: 910-920. PMID 11314026 DOI: 10.1038/Sj.Onc.1204171 |
0.484 |
|
| 1999 |
Eischen CM, Weber JD, Roussel MF, Sherr CJ, Cleveland JL. Disruption of the ARF-Mdm2-p53 tumor suppressor pathway in Myc-induced lymphomagenesis. Genes & Development. 13: 2658-69. PMID 10541552 DOI: 10.1101/Gad.13.20.2658 |
0.555 |
|
| 1998 |
Packham G, White EL, Eischen CM, Yang H, Parganas E, Ihle JN, Grillot DA, Zambetti GP, Nuñez G, Cleveland JL. Selective regulation of Bcl-XL by a Jak kinase-dependent pathway is bypassed in murine hematopoietic malignancies. Genes & Development. 12: 2475-87. PMID 9716401 DOI: 10.1101/Gad.12.16.2475 |
0.377 |
|
| 1998 |
Zindy F, Eischen CM, Randle DH, Kamijo T, Cleveland JL, Sherr CJ, Roussel MF. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes & Development. 12: 2424-33. PMID 9694806 DOI: 10.1101/Gad.12.15.2424 |
0.551 |
|
| 1997 |
Eischen CM, Kottke TJ, Martins LM, Basi GS, Tung JS, Earnshaw WC, Leibson PJ, Kaufmann SH. Comparison of apoptosis in wild-type and Fas-resistant cells: chemotherapy-induced apoptosis is not dependent on Fas/Fas ligand interactions. Blood. 90: 935-43. PMID 9242521 DOI: 10.1182/Blood.V90.3.935.935_935_943 |
0.348 |
|
| 1997 |
Eischen CM, Leibson PJ. The Fas pathway in apoptosis. Advances in Pharmacology (San Diego, Calif.). 41: 107-32. PMID 9204143 DOI: 10.1016/S1054-3589(08)61056-X |
0.344 |
|
| Show low-probability matches. |